ZA200309232B - Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments. - Google Patents

Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments.

Info

Publication number
ZA200309232B
ZA200309232B ZA200309232A ZA200309232A ZA200309232B ZA 200309232 B ZA200309232 B ZA 200309232B ZA 200309232 A ZA200309232 A ZA 200309232A ZA 200309232 A ZA200309232 A ZA 200309232A ZA 200309232 B ZA200309232 B ZA 200309232B
Authority
ZA
South Africa
Prior art keywords
narcotics
medicaments
dependence
treating
active ingredient
Prior art date
Application number
ZA200309232A
Other languages
English (en)
Inventor
Joachim Moormann
Hermann Mucke
Klaus Opitz
Original Assignee
Arzneimittelforschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelforschung Gmbh filed Critical Arzneimittelforschung Gmbh
Publication of ZA200309232B publication Critical patent/ZA200309232B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
ZA200309232A 2001-06-18 2003-11-27 Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments. ZA200309232B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10129265A DE10129265A1 (de) 2001-06-18 2001-06-18 Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie

Publications (1)

Publication Number Publication Date
ZA200309232B true ZA200309232B (en) 2004-07-21

Family

ID=7688529

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200309232A ZA200309232B (en) 2001-06-18 2003-11-27 Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments.

Country Status (28)

Country Link
US (1) US20040192683A1 (xx)
EP (1) EP1397138B1 (xx)
JP (1) JP2005500298A (xx)
KR (1) KR20040010744A (xx)
CN (1) CN1527711A (xx)
AR (1) AR034493A1 (xx)
AT (1) ATE286397T1 (xx)
AU (1) AU2002323873B2 (xx)
BR (1) BR0211008A (xx)
CA (1) CA2450787C (xx)
CZ (1) CZ299951B6 (xx)
DE (2) DE10129265A1 (xx)
EA (1) EA006647B1 (xx)
ES (1) ES2236551T3 (xx)
HK (1) HK1063292A1 (xx)
HU (1) HUP0400865A3 (xx)
IL (2) IL159345A0 (xx)
MX (1) MXPA03011825A (xx)
MY (1) MY129726A (xx)
NO (1) NO20035458D0 (xx)
NZ (1) NZ529944A (xx)
PL (1) PL367207A1 (xx)
PT (1) PT1397138E (xx)
SK (1) SK287180B6 (xx)
TW (1) TWI325320B (xx)
UA (1) UA76753C2 (xx)
WO (1) WO2002102388A2 (xx)
ZA (1) ZA200309232B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10318714B4 (de) * 2003-04-25 2006-03-23 Hf Arzneimittelforschung Gmbh Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE102004048927A1 (de) * 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
KR101406456B1 (ko) 2005-04-06 2014-06-20 아다마스 파마슈티칼스, 인코포레이티드 Ｃｎｓ 장애의 치료를 위한 방법 및 조성물
PL1895994T3 (pl) * 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
CN102408548B (zh) 2005-09-01 2013-05-15 布勒公司 聚对苯二甲酸乙二醇酯的制造方法
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
CA2781830C (en) 2009-02-12 2018-03-27 Indiana University Research & Technology Corporation Materials and methods for treating developmental disorders including comorbid and idiopathic autism
BR112012013487A2 (pt) 2009-12-02 2017-10-03 Adamas Pharmaceuticals Inc Composições de amantadina e métodos de uso
WO2012050922A2 (en) 2010-09-28 2012-04-19 Depomed, Inc. Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
RS65198B1 (sr) * 2010-12-03 2024-03-29 Nalpropion Pharmaceuticals Llc Povećana biodostupnost leka u terapiji naltreksonom
WO2013160728A1 (en) 2012-04-26 2013-10-31 Alma Mater Studiorum - Universita' Di Bologna Dual targeting compounds for the treatment of alzheimer's disease
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
TWI678202B (zh) * 2016-12-14 2019-12-01 陸汝斌 組合物用於製備治療酒癮或酒精濫用之藥物的用途
CN117860718A (zh) 2017-08-24 2024-04-12 阿达玛斯药物有限责任公司 金刚烷胺组合物、其制备和使用方法
BG67408B1 (bg) * 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3843239C1 (xx) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
DE4010079A1 (de) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
BR9509406A (pt) * 1994-10-21 1998-11-03 Waldheim Pharmazeutica Ges M B Processo para a preparação de 4a,5,9,10,11,12,-hedaxidro-6h-benzofuro(3a,3,2,-ef) [2] benzazepina
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
EP0945133A1 (en) * 1998-03-26 1999-09-29 Lipha Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
AU768990C (en) * 1998-04-17 2005-04-14 Prescient Neuropharma Inc. Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Also Published As

Publication number Publication date
IL159345A (en) 2009-02-11
CN1527711A (zh) 2004-09-08
HUP0400865A2 (hu) 2004-07-28
EA200400041A1 (ru) 2004-04-29
MXPA03011825A (es) 2005-03-07
CA2450787A1 (en) 2002-12-27
JP2005500298A (ja) 2005-01-06
NO20035458D0 (no) 2003-12-08
EA006647B1 (ru) 2006-02-24
HUP0400865A3 (en) 2011-03-28
PT1397138E (pt) 2005-04-29
EP1397138B1 (de) 2005-01-05
SK15652003A3 (sk) 2004-04-06
ES2236551T3 (es) 2005-07-16
UA76753C2 (uk) 2006-09-15
AR034493A1 (es) 2004-02-25
WO2002102388A2 (de) 2002-12-27
KR20040010744A (ko) 2004-01-31
EP1397138A2 (de) 2004-03-17
IL159345A0 (en) 2004-06-01
CZ299951B6 (cs) 2009-01-07
TWI325320B (en) 2010-06-01
ATE286397T1 (de) 2005-01-15
HK1063292A1 (en) 2004-12-24
SK287180B6 (sk) 2010-02-08
DE50201958D1 (de) 2005-02-10
DE10129265A1 (de) 2003-01-02
CZ20033390A3 (en) 2004-03-17
WO2002102388A3 (de) 2003-09-18
US20040192683A1 (en) 2004-09-30
PL367207A1 (en) 2005-02-21
MY129726A (en) 2007-04-30
CA2450787C (en) 2009-06-02
NZ529944A (en) 2007-02-23
BR0211008A (pt) 2004-10-26
AU2002323873B2 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
ZA200309232B (en) Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments.
MXPA03003853A (es) Abastecedor de medicamentos.
HK1036230A1 (en) Drug delivery devices.
ZA200410015B (en) Pharmaceutical salts.
HK1048427A1 (en) Drug delivery device.
MXPA03006884A (es) Formulacion farmaceutica.
AU1846702A (en) Anti-proliferative drugs
HUP0002628A2 (en) Pharmaceutical combinations for treating diabetes
AU2001261669A1 (en) Lockout mechanism for aerosol drug delivery devices
MXPA03005018A (es) Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso.
MXPA03005988A (es) Dispositivo para suministro de volumen liquido.
MXPA03005019A (es) Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso.
MXPA03002874A (es) Sistema de suministro de pesticida.
AU2001261425A1 (en) Cases for medication delivery devices
IL161940A0 (en) Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
MXPA03007641A (es) Formulacion farmaceutica.
ZA200110173B (en) Safety syringe.
MXPA03009804A (es) DISPENSADOR DE FORMAS DE DOSIFICACIoN SoLIDAS.
EG23318A (en) Substituted aromatic amide derivative, intermediate thereof agrohorticultural insecticide containingthereof and method for the use thereof.
ZA99283B (en) Inhaler for medication.
AP2004002955A0 (en) Weed control doses.
ZA200402729B (en) Pharmaceutical formulation comprising (R) -bicalutamide.
ZA200304928B (en) Medicament containing a polyamine as an active substance.
MXPA03007272A (es) Formulacion de medicamento que contiene agonista muscarinico.
HK1054932A1 (en) Cyclic substituted aminomethyl compounds and medicaments containing said compounds.